Lannett Co Inc (LCI) Shares are Down -3.66%

Lannett Co Inc (LCI) has risen sharply, recording gains of 10.35% in the past 4 weeks. However, the stock has corrected -3.66% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 9.22% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

The stock has recorded a 20-day Moving Average of 1.32% and the 50-Day Moving Average is 14.62%. Lannett Co Inc (NYSE:LCI): On Fridays trading session , Opening price of the stock was $31.49 with an intraday high of $31.61. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $30.79. However, the stock managed to close at $31.36, a loss of 1.07% for the day. On the previous day, the stock had closed at $31.7. The total traded volume of the day was 600,451 shares.


The company Insiders own 15.1% of Lannett Co Inc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -83.94% . Institutional Investors own 76.95% of Lannett Co Inc shares. During last six month period, the net percent change held by insiders has seen a change of -84.44%. Also, Deutsche Bank initiates coverage on Lannett Co Inc (NYSE:LCI) The shares have been rated Hold. The rating by the firm was issued on June 29, 2016.

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Companys products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.